About Heat shock 70 kDa protein 14
Heat shock 70 kDa protein 14 (HSPA14) is a protein
from Homo sapiens identified by UniProt accession
Q0VDF9, 509 residues long.
MolForge cross-references it against 0 known binders and
40 disease associations.
Target properties
| Protein name | Heat shock 70 kDa protein 14 |
| UniProt accession | Q0VDF9 |
| Gene | HSPA14 |
| Organism | Homo sapiens |
| Length | 509 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (40)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.50
- lymphocyte count · score 0.19
- breast adenocarcinoma · score 0.18
- protein measurement · score 0.14
- blood protein measurement · score 0.08
- cortical thickness · score 0.06
- neuroimaging measurement · score 0.06
- hepatocellular carcinoma · score 0.06
- brain measurement · score 0.06
- cotinine glucuronidation measurement · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q0VDF9-F1 | alphafold | PREDICTED | 91.39 | — |
Amino-acid sequence (509 residues)
MAAIGVHLGC TSACVAVYKD GRAGVVANDA GDRVTPAVVA YSENEEIVGL AAKQSRIRNI SNTVMKVKQI LGRSSSDPQA QKYIAESKCL VIEKNGKLRY EIDTGEETKF VNPEDVARLI FSKMKETAHS VLGSDANDVV ITVPFDFGEK QKNALGEAAR AAGFNVLRLI HEPSAALLAY GIGQDSPTGK SNILVFKLGG TSLSLSVMEV NSGIYRVLST NTDDNIGGAH FTETLAQYLA SEFQRSFKHD VRGNARAMMK LTNSAEVAKH SLSTLGSANC FLDSLYEGQD FDCNVSRARF ELLCSPLFNK CIEAIRGLLD QNGFTADDIN KVVLCGGSSR IPKLQQLIKD LFPAVELLNS IPPDEVIPIG AAIEAGILIG KENLLVEDSL MIECSARDIL VKGVDESGAS RFTVLFPSGT PLPARRQHTL QAPGSISSVC LELYESDGKN SAKEETKFAQ VVLQDLDKKE NGLRDILAVL TMKRDGSLHV TCTDQETGKC EAISIEIAS
Explore Heat shock 70 kDa protein 14 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets